| Literature DB >> 29311857 |
Ariane Saliani1, Blanche Perraud1, Tanguy Duval1, Nikola Stikov1,2, Serge Rossignol3, Julien Cohen-Adad1,4.
Abstract
Characterizing precisely the microstructure of axons, their density, size and myelination is of interest for the neuroscientific community, for example to help maximize the outcome of studies on white matter (WM) pathologies of the spinal cord (SC). The existence of a comprehensive and structured database of axonal measurements in healthy and disease models could help the validation of results obtained by different researchers. The purpose of this article is to provide such a database of healthy SC WM, to discuss the potential sources of variability and to suggest avenues for robust and accurate quantification of axon morphometry based on novel acquisition and processing techniques. The article is organized in three sections. The first section reviews morphometric results across species according to range of densities and counts of myelinated axons, axon diameter and myelin thickness, and characteristics of unmyelinated axons in different regions. The second section discusses the sources of variability across studies, such as age, sex, spinal pathways, spinal levels, statistical power and terminology in regard to tracts and protocols. The third section presents new techniques and perspectives that could benefit histology studies. For example, coherent anti-stokes Raman spectroscopy (CARS) imaging can provide sub-micrometric resolution without the need for fixation and staining, while slide scanners and stitching algorithms can provide full cross-sectional area of SC. In combination with these acquisition techniques, automatic segmentation algorithms for delineating axons and myelin sheath can help provide large-scale statistics on axon morphometry.Entities:
Keywords: axons; histology; morphology; myelin; spinal cord; white matter
Year: 2017 PMID: 29311857 PMCID: PMC5743665 DOI: 10.3389/fnana.2017.00129
Source DB: PubMed Journal: Front Neuroanat ISSN: 1662-5129 Impact factor: 3.856
Figure 1Atlas representing the location of white matter tracts in the human spinal cord at (Top) mid-cervical and (Bottom) lumbar levels. Reproduced with permission from Standring (2008).
Counts and densities of myelinated fibers in nervous tissue (brainstem and spinal cord) in various species.
| Rat | Pyramidal tract (brainstem) | 91,000 | Electron | Leenen et al., | |
| Pyramidal tract (brainstem) | 378,300 | 140,000 | Electron | Leenen et al., | |
| Pyramidal tract (spinal cervical 2 level) | 483,300 | 43,000 | Electron | Leenen et al., | |
| Sacral spinal cord ; Lateral funiculus | 55,000 | Electron | Chung and Coggeshall, | ||
| Sacral spinal cord; ventral funiculus | 26,000 | Electron | Chung and Coggeshall, | ||
| Pyramidal tract (brainstem) | 88,908–144,704 (mean 111,600) | Both | Dunkerley and Duncan, | ||
| Pyramidal tract | 73,000 | Probably optical | Lassek and Rasmussen, | ||
| Pyramidal tract (cervical) | 137,000 | Optical | Brown, | ||
| Pyramidal tract (brainstem) | 188,395–163,530 | Electron | Harding and Towe, | ||
| Cat | Pyramidal tract (brainstem) | 186,000 | Lassek and Rasmussen, | ||
| Pyramidal tract (brainstem) | 80,000 | Optical | van Crevel and Verhaart, | ||
| Pyramidal tract (brainstem) | 368,044 | Electron | Thomas et al., | ||
| Dorsal funiculus, sacral 2 spinal level | 34,520 ± 2,436 | Electron | Chung et al., | ||
| Lateral funiculus, sacral 2 spinal level | 159,774 ± 7,762 | Electron | Chung et al., | ||
| Ventral funiculus, sacral 2 spinal level | 74,431 ± 17,936 | Electron | Chung et al., | ||
| Pyramidal tract (brainstem) | 143,291 | 356,583 | Electron | Biedenbach et al., | |
| Monkey | Pyramidal tract | 554,000 | Optical | Lassek and Rasmussen, | |
| Pyramidal tract | 435,627 | Optical | Russel and Demyer, | ||
| Pyramidal tract | 594,000 | Electron | Firmin et al., | ||
| Human | Pyramidal tract | 1,087,200 | Demyer, | ||
| Pyramidal tract | 101,400 | Towe, | |||
| Pyramidal tract (brainstem) | 50,000–100,000 | 663,000–884,000 | Electron | Graf and Schramm, | |
| Pyramidal tract | 8,400–9,210 | 48,768–67,419 | Optical | Wada et al., | |
| Fasciculus gracilis (C3) | 19,647–35,773 (mean: 25,267) | Ohnishi et al., | |||
| Fasciculus gracilis (T5) | 17,804–29,486 (mean: 23,069) | Ohnishi et al., |
The terminology used is the authors'. Strictly speaking, the pyramidal tract is only in the midbrain and not in the SC.
In some cases, there was uncertainty about whether the authors included only myelinated or both myelinated and unmyelinated fibers in their counts, as mentioned by this note.
In other cases, the authors specified that their counts included unmyelinated fibers.
Morphometric data on myelinated axons in nervous tissue obtained from various species.
| Rat | Pyramidal tract (brainstem) | 0.80 1.19 (fibers) | 0.10–4 0.25–5 (fibers) | 90% < 1.5 μm | Leenen et al., | ||
| Pyramidal tract (brainstem and cervical 2 spinal level) | 0.72 1.08 (fiber) | 0.13–4.92 0.25–6.03 (fiber) | 0.65 | 0.2 | Leenen et al., | ||
| Pyramidal tract (midbulbar) | 1.054 (fiber) 1.182 (fiber, with shrinkage correction) | Max. 3.7 and 5.2 (fibers) | 50% < 1.2 μm (fibers) | Harding and Towe, | |||
| Corticospinal tract (cervical 2) | 0.68 (ipsilateral ventral) 0.72 (main) | Brösamle and Schwab, | |||||
| Corticospinal tract (cervical) | 0.5–3 | Joosten and Gribnau, | |||||
| Cat | Pyramidal tract (brainstem) | <10 (fibers) | 73% 0–2 μm 20% 2–4 μm 5% 4–6 μm 2% > 6 μm (fibers) | van Crevel and Verhaart, | |||
| Pyramidal tract (brainstem) | 1.98 (median: 1.60) | 0.25–23 | > 50% < 2 μm 1% > 9 μm 25% 0.5–1 μm 20% 1–1.5 μm | Biedenbach et al., | |||
| Fasciculus gracilis (cervical) | <1–15 | 97% < 8 μm 50% 2–5 μm | Thomas et al., | ||||
| Monkey | Pyramidal tract (brainstem) | 0.4–6 | Ralston et al., | ||||
| Pyramidal tract (brainstem) | 0.91 (median: 0.68) Fiber: 1.32 (median: 0.97) | 0.04–9.48 | 52% < 1 μm 14% < 0.5 μm | Firmin et al., | |||
| Human | Pyramidal tract (brainstem) | 70% < 1 μm 84% < 2 μm (fibers) | Lassek and Rasmussen, | ||||
| Pyramidal tract (brainstem) | 1–20 (fibers) | 90% > 1 μm (fibers) | Verhaart, | ||||
| Pyramidal tract (brainstem) | ~0.3–10 | 88% < 4 μm 10.77% 4–10 μm 1.4% > 10 μm (fibers) | 0.6 for axon < 0.5 μm >0.6 for axon >0.5 μm | Terao et al., |
Studies marked with (
) have been conducted through electron microscopy, the ones marked with
(
) have been conducted with optical microscopy.
Morphometric data of unmyelinated fibers in nervous tissue (brainstem or spinal cord).
| Rat | Pyramidal | Medullary pyramid | 0.05–1 | 0.16 | Leenen et al., | |
| Corticospinal | Main component | 0.72–1.48 | 0.72 ± 0.05 | Brösamle and Schwab, | ||
| Corticospinal | Ipsilateral ventral | 0.68 ± 0.04 | Brösamle and Schwab, | |||
| Cat | Lissauer | Thoracic and lumbar | Chung et al., | |||
| Pyramidal | Medulla pyramid | 0.05–0.6 | 0.18 | 0.10–0.30 = 94% 0.01% > 0.5 | Thomas et al., | |
| Pyramidal | Sacral 2 | 0.1–1 | Chung et al., | |||
| Pyramidal | Medullary pyramid | 0.05–0.6 | 0.18 | Biedenbach et al., | ||
| Monkey | Pyramidal | Medullary pyramid | 0.07–2.25 | Ralston et al., |
All those studies have been conducted with electron microscopy.
Counts and densities of unmyelinated fibers in brainstem and spinal cord.
| Rat | Pyramidal tract (brainstem) | 518,700 | 140,000 | Leenen et al., | |
| Pyramidal tract (brainstem) | 133,000 | 12 | Leenen et al., | ||
| Pyramidal tract (cervical) | 396,200 | 35,000 | 13 | Leenen et al., | |
| Cat | Pyramidal tract | 20,768 | 47,645 | 12 | Biedenbach et al., |
| Pyramidal tract | 10,696 and 15,166 | 20,750–63,290 | 8 and 15 | Thomas et al., | |
| Dorsal funiculus, sacral 2 | 8,488 ± 845 | 29 | Chung et al., | ||
| Dorsal funiculus, sacral 2 | 19,559 ± 1,465 | 36 | Chung et al., | ||
| Lateral funiculus, sacral 2 | 126,763 ± 29,858 | 44 | Chung et al., | ||
| Ventral funiculus, sacral 2 | 32,182 ± 6,587 | 30 | Chung et al., | ||
| WM sacral 2 | 45 | Chung et al., | |||
| Tract of Lissauer, sacral 1 and sacral 3 | 49,500 | 80 | Chung et al., |
All those studies have been conducted with electron microscopy.
Figure 2Localization of the major white matter tracts of the mouse SC, at C8, T7, L3, and S2 levels. Adapted with permission from (Watson and Harrison, 2012). 1Sp, lamina 1; 2Spl, lamina 2 inner part; 2SpO, lamina 2 outer part; 3Sp, lamina 3; 7Sp, lamina 7; CC, central canal; crts, caudal reticulospinal tract; cu, cuneate fasciculus; dcs, dorsal corticospinal tract; dsc, dorsal spinocerebellar tract; dl, dorsolateral fasciculus; dlst, dorsolateral spinothalamic tract; gr, gracile fasciculus; IML, intermediolateral column; lst, lateral spinothalamic tract; LSp, lateral spinal nucleus; lvs, lateral vestibulospinal tract; mvs, medial vestibulospinal tract; pdsc, postsynaptic dorsal column pathway; rrts, rostral reticulospinal tract; rs, rubrospinal tract; SPSy, sacral parasympathic nucleus; vsc, ventral spinocerebellar tract; vst, ventral spinothalamic tract.
Evolution of morphometric data obtained from nervous tissue according to age in different species.
| Human spinal cord L1 | ⇓ | ⇓ | Zhou et al., | |||
| Human fasciculus gracilis C3 | ⇓ | Ohnishi et al., | ||||
| Human corticospinal tract | ⇓ (small fibers) | Terao et al., | ||||
| Human corticospinal tract | ⇓ | Nakanishi et al., | ||||
| Human sural nerve | ⇓ but ⇑ for small axons | ⇓ | Constant until ≅ 60 | Jacobs and Love, | ||
| Human optic nerve | Constant | Preferential large fiber loss | Repka and Quigley, | |||
| Human superior laryngeal nerve | Constant (myelinated fibers) | No significant difference | Tiago et al., | |||
| Human superior laryngeal nerve | ⇓ (myelinated fibers) | Constant | ⇓ of 1–2 μm fibers and 0–0.5 μm axons | Mortelliti et al., | ||
| Human recurrent laryngeal nerve | ⇓ (myelinated fibers) | ⇓ of 1–3 μm axons | Tiago et al., | |||
| Monkey optic nerve | ⇓ | Constant | Morrison et al., | |||
| Monkey optic nerve | Constant | ⇑ | Fortune et al., | |||
| Mice olfactory nerve | Constant | ⇓ | Watanabe et al., | |||
| Rat hypoglossal nerve (male) | Constant (myelinated) | ⇓ | ⇓ | ⇓ | Soltanpour et al., | |
| Rat sural nerve | Constant for myelinated | ⇓ (myelinated) | ⇑ myelinated and axon diameter | Myelin sheath area ⇑ | Constant | Jeronimo et al., |
| Rat brain | ⇑ | ⇑for F ⇓for M | Yang et al., |
F, female; M, male.
Evolution of morphometric data obtained from nervous tissue according to sex in different species.
| Human laryngeal nerve | M > F | M > F | De Campos et al., | |||
| Rat phrenic nerve | Myelinated: F > M | Myelinated: F > M | Similar | Similar | Rodrigues et al., | |
| Rat brain | Young: M > F Old: F > M | Similar (myelinated) | Yang et al., | |||
| Mice spinal cord cervical ventral funiculus | OLG: M > F MBP levels: M > F | Cerghet et al., |
F, female; M, male; OLG, oligodendrocytes.
Histological protocols for ultrastructural observation of nervous tissue in literature.
| Monkey | 2% Glutaraldehyde – 2% PFA | Ralston et al., | |||
| 1% glutaraldehyde – 1% PFA | 1% glutaraldehyde – 1% PFA | Osmium tetroxide 1% (1.5 h) | 1% toluidine blue (OM) 1% uranyl acetate and 1% lead acetate (EM) | Firmin et al., | |
| Cat | 1.5% glutaraldehyde – 1% PFA – 0.1% picric acid | 1.5% glutaraldehyde – 1% PFA – 0.1% picric acid | Osmium tetroxide 1–1.5% potassium ferricyanide | 1% uranyl acetate and 0.1% lead citrate (EM) | Biedenbach et al., |
| Rat | 0.5% PFA – 1.5% glutaraldehyde – 0.1% picric acid | 0.5% PFA – 1.5% glutaraldehyde – 0.1% picric acid | Osmium tetroxide 2–0.15% potassium ferrocyanide (EM) | 5% toluidine blue (OM) Uranyl acetate and lead citrate (EM) | Leenen et al., |
| 0.5% glutaraldehyde – 4% PFA | 0.5% glutaraldehyde – 4% PFA (2nd animal) | Osmium tetroxide 2% (1st animal) Osmium tetroxide 4–1.5% potassium ferrocyanide (2nd animal) | Methylene blue-azure II (1st animal) Methylene blue-azure II (OM) or 4% uranyl acetate and 11.6% lead acetate (EM) (2nd animal) | Harding and Towe, | |
| Human | 10% formalin (3.7–4.0% formaldehyde) through the femoral artery | 10% formalin (1 week) 5% potassium dichromate and 5% potassium chromate (2 weeks) | luxol fast blue-periodic acid Schiff-hematoxylin (LPH) | Souma et al., |
Figure 3Image of a cross-section of a mouse spinal cord based on coherent anti-stokes Raman spectroscopy, which is tuned to exhibit signal from myelin sheath. Axial axons appear in red, while lateral fibers and some vessels appear in green. Zoomed panels focus on the dorsal (top right) and ventral white matter (bottom right) and in the ascending reticulospinal/fasciculus proprius region (middle right). Courtesy of Erik Bélanger, Sophie Laffray and Daniel Côté.
Figure 4Example of a whole slice of a human SC at L5 level, imaged with electron microscopy. The middle panel focuses in the ventral region, and the right panel shows an overlay of myelin segmentation, color-coded for axon diameter (red: small, white/yellow: big). Segmentation was performed using AxonSeg (https://github.com/neuropoly/axonseg).